These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2365194)

  • 1. Concentrative biliary secretion of ceftriaxone. Inhibition of lipid secretion and precipitation of calcium ceftriaxone in bile.
    Xia Y; Lambert KJ; Schteingart CD; GU JJ; Hofmann AF
    Gastroenterology; 1990 Aug; 99(2):454-65. PubMed ID: 2365194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.
    Yoon YB; Hagey LR; Hofmann AF; Gurantz D; Michelotti EL; Steinbach JH
    Gastroenterology; 1986 Apr; 90(4):837-52. PubMed ID: 3949115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary secretion and hepatic metabolism of taurine-conjugated 7 alpha-hydroxy and 7 beta-hydroxy bile acids in the dog. Defective hepatic transport and bile hyposecretion.
    Nakagaki M; Danzinger RG; Hofmann AF; DiPietro RA
    Gastroenterology; 1984 Sep; 87(3):647-59. PubMed ID: 6745618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo studies of biliary ceftriaxone excretion and solubility in guinea pig hepatic bile.
    Purdum PP; Shiffman ML; Moore EW
    J Lab Clin Med; 1992 Oct; 120(4):604-13. PubMed ID: 1402336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing effects of hydroxy-7-oxotaurine-conjugated bile acids on bile flow and biliary lipid secretion in dogs.
    Danzinger RG; Nakagaki M; Hofmann AF; Ljungwe EB
    Am J Physiol; 1984 Feb; 246(2 Pt 1):G166-72. PubMed ID: 6546473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of biliary lipid and protein secretion by cyclosporine A in the rat.
    Galán AI; Román ID; Muñoz ME; Cava F; Gonzalez-Buitrago JM; Esteller A; Jimenez R
    Biochem Pharmacol; 1992 Sep; 44(6):1105-13. PubMed ID: 1417934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of biliary phospholipid secretion. Effect of continuous and discontinuous infusion of taurocholate on biliary phospholipid secretion.
    Rahman K; Hammond TG; Lowe PJ; Barnwell SG; Clark B; Coleman R
    Biochem J; 1986 Mar; 234(2):421-7. PubMed ID: 3718477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choleresis and inhibition of biliary lipid secretion induced by piperacillin in the rat.
    González P; Mauriz JL; Jiménez R; González-Gallego J; Tuñón MJ
    Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):880-4. PubMed ID: 12207566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of biliary phospholipid and cholesterol secretion by cefoperazone.
    Pattinson NR; Willis KE; Chapman BA
    Dig Dis Sci; 1987 Jun; 32(6):615-9. PubMed ID: 3568949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of side-chain charge on hepatic transport of bile acids and bile acid analogues.
    Anwer MS; O'Maille ER; Hofmann AF; DiPietro RA; Michelotti E
    Am J Physiol; 1985 Oct; 249(4 Pt 1):G479-88. PubMed ID: 4050998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and effects on biliary lipid secretion of murocholic acid in the hamster.
    Parquet M; Legrand-defretin V; Riottot M; Karpouza A; Lutton C
    J Hepatol; 1990 Jul; 11(1):111-9. PubMed ID: 2398262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary lipid secretion in the rat. The uncoupling of biliary cholesterol and phospholipid secretion from bile acid secretion by sulfated glycolithocholic acid.
    Kuipers F; Derksen JP; Gerding A; Scherphof GL; Vonk RJ
    Biochim Biophys Acta; 1987 Nov; 922(2):136-44. PubMed ID: 3676338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestasis, metabolism and biliary lipid secretion during perfusion of rat liver with different bile salts.
    Baumgartner U; Schölmerich J; Leible P; Farthmann EH
    Biochim Biophys Acta; 1992 Apr; 1125(2):142-9. PubMed ID: 1571357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of biliary cholesterol and phospholipid secretion by cefmetazole. The role of vesicular transport and of canalicular events.
    Cava F; Gonzalez J; Gonzalez-Buitrago JM; Muriel C; Jimenez R
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):591-5. PubMed ID: 1674860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of progesterone on the regulatory mechanisms of biliary cholesterol secretion in the rat.
    Nervi FO; Del Pozo R; Covarrubias CF; Ronco BO
    Hepatology; 1983; 3(3):360-7. PubMed ID: 6840681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic and ileal transport and effect on biliary secretion of norursocholic acid and its conjugates in rats.
    Lillienau J; Hagey LR; Borgström B
    Am J Physiol; 1991 Dec; 261(6 Pt 1):G1057-64. PubMed ID: 1767847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility.
    Shiffman ML; Keith FB; Moore EW
    Gastroenterology; 1990 Dec; 99(6):1772-8. PubMed ID: 2227290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of some sulfonate analogues of ursodeoxycholic acid on biliary lipid secretion in the rat.
    Mikami T; Kihira K; Ikawa S; Yoshii M; Mosbach EH; Hoshita T
    J Lipid Res; 1996 Jun; 37(6):1181-8. PubMed ID: 8808752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory action of cyclobutyrol on the secretion of biliary cholesterol and phospholipids.
    Monte MJ; Parslow RA; Coleman R
    Biochem J; 1990 Feb; 266(1):165-71. PubMed ID: 2310370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monensin action on the Golgi complex in perfused rat liver: evidence against bile salt vesicular transport.
    Reynier MO; Abou Hashieh I; Crotte C; Carbuccia N; Richard B; Gérolami A
    Gastroenterology; 1992 Jun; 102(6):2024-32. PubMed ID: 1587420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.